Abstracts

Cardiovascular Disease in HIV Patients: An Emerging Paradigm and Call to Action

Cardiovascular disease (CVD) has emerged as an important co-morbidity in HIV-infected patients. The relative risk of CVD, including myocardial infarction and stroke, is increased in HIV patients compared to age and gender-matched non HIV patients. Although some traditional risks, including smoking, are increased in HIV-infected patients and should be targeted for treatment, very often this…

The Price of Selling Sex: HIV Among Female Sex Workers—The Context and the Public Health Response

Background: HIV prevalence among female sex workers (FSW) remains disproportionately high, on average 13 times higher than among the general population in low and middle income countries. FSW in sub-Saharan Africa are most severely affected. Effective HIV prevention interventions among FSWs include condom promotion, STI management, HIV testing and counselling, gender-based violence prevention, and community…

Statin Therapy Reduces Coronary Noncalcified Plaque Volume in HIV Patients: A Randomized Controlled Trial

Background: Statins reduce cardiovascular events and deter progression of atherosclerosis. No studies have yet assessed the ability of statin treatment to achieve regression of coronary atherosclerosis in HIV-infected patients, a population demonstrated to have elevated risk of myocardial infarction. Methods: In a randomized, double-blind, placebo-controlled trial, 40 HIV-infected participants with subclinical coronary atherosclerosis and low…

Rosuvastatin Arrests Progression of Carotid Intima-Media Thickness in Treated HIV

Background: Statins slow progression of carotid intima-media thickness (IMT) and prevent cardiovascular events in HIV uninfected subjects. To what degree they may slow progression of carotid disease in HIV-infected patients on antiretroviral therapy (ART) is unknown. Methods: SATURN-HIV was a 96-week double-blind, randomized clinical trial of 10 mg daily rosuvastatin versus placebo among 147 HIV-infected…

Calcified Plaque Burden Is Associated With Serum Gut Microbiota-Generated TMA in HIV

Background: Some gut microbiota-generated metabolites of phosphatidylcholine are recognized to be pro-atherogenic. The HIV population is more vulnerable to cardiovascular disease (CVD) than the general population and can develop impaired intestinal wall integrity and dysbiosis associated with inflammation. We investigated the novel relationship between microbiota-derived choline-related metabolites and coronary atherosclerosis in HIV. Methods: 155 HIV-infected…

AIDS Lymphoma: Advances and Existing Challenges

Despite dramatic advances in anti-retroviral therapy, HIV related lymphoma remains a challenge. Lymphoma is the largest contributor to cancer deaths among HIV infected persons and accounts for about 10% of all deaths. Though the incidence has changed, HIV infected person with good CD4 counts still have a marked increase risk of lymphoma with the exception…

HIV Risks and Vulnerabilities Among Gay Men and Other Men Who Have Sex With Men Across Sub-Saharan Africa

In the context of the generalized HIV epidemics across Sub-Saharan Africa, it is often proposed that key populations with specific HIV acquisition and transmission risk factors are less relevant because HIV transmission is sustained among reproductive age adults with average HIV acquisition and transmission risks. While some countries in Western and Northern Africa have concentrated…